Literature DB >> 10669857

Helper T-cell responses elicited by Der p 1-pulsed dendritic cells and recombinant IL-12 in atopic and healthy subjects.

D De Wit1, Z Amraoui, B Vincart, O Michel, A Michils, L Van Overvelt, F Willems, M Goldman.   

Abstract

BACKGROUND: Environmental allergens, such as Dermatophagoides pteronyssinus group 1 antigen (Der p 1), induce T(H2)-type responses in atopic patients, whereas healthy individuals have T(H1)-type responses to the same antigens. Because of their efficient synthesis of IL-12, dendritic cells (DCs) are potent inducers of T(H1)-type immune responses.
OBJECTIVE: We sought to determine whether DCs would skew allergen-specific T(H2)-type responses from atopic individuals.
METHODS: Purified CD4(+) T cells from healthy donors or atopic individuals were cultured in the absence or presence of recombinant (r)IL-12 with DCs derived from PBMCs and pulsed with Der p 1. Supernatants of DC-T cell cocultures were assayed by ELISA for IL-5 and IFN-gamma.
RESULTS: A T(H1)-type response developed in purified CD4(+) T cells from healthy donors in response to Der p 1-pulsed DCs, as indicated by high levels of IFN-gamma in culture supernatants. In contrast, CD4(+) T cells from atopic donors displayed a T(H2)-type profile characterized by high levels of IL-5 and low levels of IFN-gamma. The addition of rIL-12 (10 ng/mL) to DC-T cell cocultures resulted in the induction of IFN-gamma secretion by Der p 1-specific CD4(+) T cells from atopic patients, whereas their production of IL-5 was not inhibited. Using flow cytometry after intracytoplasmic staining, we found that IFN-gamma and IL-5 were secreted by distinct CD4(+) T-cell subpopulations.
CONCLUSION: The cytokine profile of Der p 1-specific T(H2)-like cells from atopic individuals is maintained when the allergen is presented by DCs, even in the presence of exogenous rIL-12.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669857     DOI: 10.1016/s0091-6749(00)90086-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

Review 1.  Immunological mechanisms in specific immunotherapy.

Authors:  Carsten B Schmidt-Weber; Kurt Blaser
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

2.  Retagging identifies dendritic cell-specific intercellular adhesion molecule-3 (ICAM3)-grabbing non-integrin (DC-SIGN) protein as a novel receptor for a major allergen from house dust mite.

Authors:  Mohamed Emara; Pierre-Joseph Royer; Jafar Mahdavi; Farouk Shakib; Amir M Ghaemmaghami
Journal:  J Biol Chem       Date:  2011-12-28       Impact factor: 5.157

Review 3.  Dendritic Cells and Their Role in Allergy: Uptake, Proteolytic Processing and Presentation of Allergens.

Authors:  Piotr Humeniuk; Pawel Dubiela; Karin Hoffmann-Sommergruber
Journal:  Int J Mol Sci       Date:  2017-07-11       Impact factor: 5.923

4.  The effect of caffeic acid phenethyl ester on the functions of human monocyte-derived dendritic cells.

Authors:  Li-Chieh Wang; Yu-Li Lin; Yu-Chih Liang; Yao-Hsu Yang; Jyh-Hong Lee; Hsin-Hui Yu; Wen-Mein Wu; Bor-Luen Chiang
Journal:  BMC Immunol       Date:  2009-07-16       Impact factor: 3.615

5.  Th2 responses elicited by nasal epithelial cells exposed to house dust mite extract.

Authors:  Seung-Heon Shin; Mi-Kyung Ye
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

6.  Effects of cytokine milieu secreted by BCG-treated dendritic cells on allergen-specific Th immune response.

Authors:  Youngil I Koh; Inseon S Choi; Je-Jung Lee
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

Review 7.  Vaccinia virus pathogenicity in atopic dermatitis is caused by allergen-induced immune response that prevents the antiviral cellular and humoral immunity.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2003-12       Impact factor: 2.198

8.  BCG-induced dendritic cell responses and suppression of interleukin-5 production from T cells in atopic asthmatics.

Authors:  Inseon S Choi; Xiang-Hua Lin; Young-Ah Koh; Yong Cui
Journal:  J Korean Med Sci       Date:  2008-08       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.